Time to resolution of iodine‐123 metaiodobenzylguanidine ( 123I‐MIBG ) avidity and local control outcomes for high‐risk neuroblastoma following radiation therapy
Year: 2022
Type: article
Study design: Observational Study
Institutions: Stanford University, Stanford Medicine
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4307433386
